top of page

Meet the Team

Our mission-driven team is united by a shared sense of purpose and urgency: to bring a life-changing treatment to CMT1A patients as quickly as possible.

Ari on my shoulders
David Apple | Founder & CEO

​    Dedication.

  • My 4 yr old son has CMT1A. He had an earlier onset and has a more severe presentation.

  • CMT1A is progressive, and gets worse during puberty.

  • I have a sense of urgency and will not stop until a safe treatment is available for my son.

​

  Track-record.  

  • I learn quickly.  I'm a Mechanical Engineer (Johns Hopkins) and an MBA (Imperial College London).

  • I was the first go-to-market leader at Notion ($10B) & Typeform ($1B). I advise Sequoia Capital.

  • I'm a 2x Founder. Teleconnect (acquired), Apple Sustainability (ran profitably for 5 yrs).

​

   Perspective.  

  • I'm energized by solving hard problems.

  • I'm working backwards from the unmet need.

  • LinkedIn
  • Twitter

Our Scientific Advisors.

Shark Tooth Biotech Logo

Developing treatments for CMT1A, and unlocking solutions for other neuropathies.​

Follow Us:

  • LinkedIn
  • Twitter

© 2024 by Shark Tooth Biotech. All rights reserved.

bottom of page